In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sinclair Pharma closes £8.9mm IPO

Executive Summary

Niche market pharmaceutical developer Sinclair Pharma PLC (specializing in dermatology, oral health, and oncology) has completed its IPO on the London Stock Exchange's AIM, netting £8.9mm ($15.4mm) through the sale of 9.4mm ordinary shares at 115p apiece. Selling stockholders placed an additional 9.6mm shares.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies